Danielle Bucco

Articles

Expert Explains Next Steps With Advancing CLL Care

May 23rd 2017

Richard R. Furman, MD, discusses the continued evolution of the field of chronic lymphocytic leukemia and how physicians decide on the optimal treatment sequence for their patients.

Lead Researcher Discusses FDA Approval of Pembrolizumab for Urothelial Carcinoma

May 22nd 2017

Arjun V. Balar, MD, discusses the impact of the approval of pembrolizumab and other immunotherapy agents in urothelial carcinoma, as well as the next steps with these treatments.

Study Spotlights Patient Difficulties When Opting Against Thyroid Cancer Treatment

May 19th 2017

Louise Davies, MD, discusses the experience of patients with incidentally identified thyroid cancer who choose to not receive treatment.

Study Warns Women of Premature Discontinuation of Cervical Cancer Screening

May 16th 2017

Mary C. White, ScD, MPH, discusses the unmet needs near and after the stopping age for cervical cancer screening.

Complete Surgical Metastasectomy Remains Critical Option in RCC

May 12th 2017

Bradley C. Leibovich, MD, discusses the benefits of surgery and the need for more effective drug treatments for patients with metastatic renal cell carcinoma.

Expert Discusses Success of Stereotactic Radiation in RCC

May 12th 2017

Raquibul Hannan, MD, PhD, discusses the benefits of using stereotactic radiation for patients with renal cell carcinoma and highlights ongoing trials examining the modality.

Midostaurin Approval Brings New Hope in AML

May 10th 2017

Gail J. Roboz, MD, discusses the recent FDA approval of midostaurin and what else is emerging in the treatment landscape in AML.

Neelapu Hopeful FDA Will Approve Axicabtagene Ciloleucel for NHL

May 8th 2017

Sattva S. Neelapu, MD, discusses the ZUMA-1 trial and the potential impact of these results on patients with non-Hodgkin lymphoma.

Expert Discusses Unleashing Promise of Genetic Testing in Prostate Cancer

May 8th 2017

Christopher J. Kane, MD, discusses the challenges and impact of genetic testing on patients with prostate cancer.

Frontline CLL Care Continues to Evolve

May 8th 2017

Steven Coutre, MD, discusses ongoing efforts to enhance frontline outcomes for patients with CLL.

Tripathy Highlights Neoadjuvant Advances in HER2+ Breast Cancer

May 3rd 2017

Debu Tripathy, MD, discusses current and emerging treatment strategies in the neoadjuvant setting for patients with HER2-postive breast cancer.

Expert Sheds Light on Investigative Surgical Approaches in Head and Neck Cancer

May 3rd 2017

Benjamin L. Judson, MD, highlights the importance of a multidisciplinary team and shares insight on some of the advancements related to surgery for patients with head and neck cancer.

Expert Discusses Immunotherapy Advances in Head and Neck Cancer

April 25th 2017

Barbara Burtness, MD, discusses her presentation on the current and emerging role of immunotherapy for patients with head and neck cancer.

Minimally Invasive Surgery Increasingly Used in Gynecologic Malignancies

April 24th 2017

Shana Wingo, MD, discusses the advancements being made in the field of surgery for patients with gynecologic cancers.

Exceptional Responder to Pembrolizumab Guides Immunotherapy Progress in Leiomyosarcoma

April 24th 2017

Suzanne George, MD, discusses an exceptional responder to pembrolizumab in leiomyosarcoma and the significance of these findings for further immunotherapy advances in the field.

Dreicer Discusses Emerging Agents in mCRPC

April 15th 2017

Robert Dreicer, MD, highlights several emerging treatments for patients with metastatic castration-resistant prostate cancer.

Expert Discusses State of Follicular Lymphoma Treatment in 2017

April 13th 2017

Nathan Fowler, MD, discusses the current management of high-risk follicular lymphoma and ongoing developments in the field.

Researchers Identify Predictors for Distant Metastases in HPV+ Oropharyngeal Cancer

April 13th 2017

Shlomo Koyfman, MD, discusses the findings of a recent study of patients with HPV-positive oropharyngeal cancer treated with cisplatin-based chemoradiotherapy or cetuximab-based bioradiotherapy.

Marshall Addresses Sidedness Issue in Colorectal Cancer

April 13th 2017

John L. Marshall, MD, discusses the results of the CALGB 80405 trial and other ongoing efforts to determine the underlying molecular basis for the sidedness issue in colorectal cancer.

Expert Discusses Differences Between Early-Onset and Traditional CRC

April 11th 2017

Manish Shah, MD, discusses ongoing efforts to understand the distinction between early-onset CRC and traditional CRC.